- Supported exchanges /
- F /
- 9II.F
BIOVICA INTL. SK-07 (9II F) stock market data APIs
Biovica International AB (publ), a biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America. It primarily focuses on breast cancer. The company develops DiviTum TKa, a blood-based biomarker assay that measures thymidine kinase activity, which is correlated with cell proliferation. It serves cancer institutes, pharmaceutical companies, and collaborative groups. Biovica International AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.
BIOVICA INTL. SK-07 Financial Data Overview
| 0.1624 | |
| 0.1652 | |
| - | |
| 0.1652 | |
| 0.1624 | |
| 0.1012-0.261 | |
| 18 784 K | |
| 91 515 K | |
| 7 243 K | |
| 1.403 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
BIOVICA INTL. SK-07 Fundamental Data is available in our Financial Data APIs
- Net Revenue 7 243 K
- EBITDA -118 062 000
- Earnings Per Share -0.15
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get BIOVICA INTL. SK-07 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get BIOVICA INTL. SK-07 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
